27th ASGCT Annual Meeting
BioCentriq will be attending the ASGCT 27th Annual Meeting. We’ll be in Booth #539, where you can learn all about our capabilities as a global CDMO specializing in cell therapy. Please fill out the form …
Read moreBioCentriq will be attending the ASGCT 27th Annual Meeting. We’ll be in Booth #539, where you can learn all about our capabilities as a global CDMO specializing in cell therapy. Please fill out the form …
Read moreBioCentriq will be attending the 7th CAR-TCR Summit Europe. Join David Smith, our VP of Development for the presentation of the first public CAR-T expansion data from BioCentriq’s collaboration with Terumo Blood and Cell Technologies. The data …
Read moreBioCentriq will be attending Advanced Therapies Xchange San Diego 2024. Join Alex Klarer, VP of Strategy & Innovation in San Diego on Feb 29th! Discussion topics will cover Measuring Product Potency, Autologous C&G, Allogeneic Cell Therapies, …
Read moreBioCentriq’s team will be attending and presenting at Phacilitate’s Advanced Therapies Week and will available for one-on-one meetings. Please contact us to schedule a meeting with the team.
Read moreBioCentriq will be attending the 65th ASH Annual Meeting and Exposition. Meet with Jennifer Manning, MPA, Chief Commercial Officer, and Chathuranga De Silva, Ph.D., Senior Director of Business Development to learn all about our capabilities as a …
Read moreJoin BioCentriq, your go-to partner for turning breakthrough cell therapies into reality. As a collaborative CDMO, we’re all about amplifying your innovations in cell therapy and helping you get to patient faster. Meet our distinguished …
Read moreBioCentriq will be attending the 2023 PDA/FDA Joint Regulatory Conference. Chief Quality & Compliance Officer Jackie Panter is on the planning committee and will be speaking. Meet with her to learn all about our capabilities …
Read moreBringing together experts and thought leaders, this webinar will look at a promising paradigm shift for the industry: the adoption of platform processes. Our hypothesis is that the adoption of platform processes would help cell therapy …
Read moreBioCentriq will be attending the 8th CAR-TCR Summit. Meet with Christian Rouldan, Executive Director of Business Development or Alex Klarer, VP of Business Strategy & Innovation to learn all about our capabilities as a collaborative CDMO …
Read moreBioCentriq will be attending the 15th Annual BioProcessing Summit. Meet with our MS&T and Development teams to learn all about our capabilities as a collaborative CDMO specializing in cell and gene therapy. Please fill out …
Read moreBioCentriq’s VP of Development, David Smith, Ph.D., will be attending the NIIMBL 2023 National Meeting. Schedule a one-on-one meeting with him and learn all about BioCentriq as a collaborative CDMO by filling out the form …
Read moreBioCentriq will be attending the 2023 PDA Advanced Therapy Medicinal Products Conference. Meet with Chief Quality & Compliance Officer, Jackie Panter, to learn all about our capabilities as a collaborative CDMO specializing in cell and …
Read more